Mechanistically, dual-dose Pam2ODN immunotherapy attenuated early interferon gamma-driven immunotoxicity, enhanced PRR and downstream signaling, induced essential antifungal effector cytokine pathways, and promoted recruitment, differentiation, and maturation of mononuclear phagocytes. Here, IFNG is linked to immune system toxicity.